Profile
Dr. David Johnston is an Executive VP-Global Clinical Development at PPD, Inc. Dr. Johnston was previously employed as a Senior Vice President by Laboratory Corp. of America Holdings. He also served on the board at Locus Biosciences, Inc. He received his undergraduate degree from The University of North Carolina at Greensboro and a doctorate degree from UNC School of Medicine.
Former positions of David Johnston
| Companies | Position | End |
|---|---|---|
| PPD, INC. | President | 2023-09-30 |
| THERMO FISHER SCIENTIFIC | Chief Tech/Sci/R&D Officer | - |
Locus Biosciences, Inc.
 Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Director/Board Member | - |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Corporate Officer/Principal | - |
Training of David Johnston
| The University of North Carolina at Greensboro | Undergraduate Degree |
| UNC School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Health Services |
| THERMO FISHER SCIENTIFIC | Health Technology |
| Private companies | 2 |
|---|---|
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Technology Services |
PPD, Inc.
 PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
- Stock Market
- Insiders
- David Johnston
